EUVIMEDEUVIMED entdecken
Crossref

From components to pharmaceuticals: A desirable evolution toward precision transfusion medicine

Melissa M Cushing iD, Steven L Spitalnik iD

Transfusion · 2026-11 · 66 (11) · 2450-2455

DOI: 10.1111/trf.70402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, online erschienen am 26.09.2026. Verfasst von Melissa M Cushing und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA. Die Arbeit nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Modern medicine demands pharmaceutical therapies that are dose-defined, predictable, and reproducible.1 The United States Food & Drug Administration (FDA) evaluates drugs based on purity, potency, stability, sterility, and consistency.2,3 Yet transfusion medicine continues to rely primarily on "units" of biologic products (e.g., red blood cells (RBCs), platelets, plasma), the composition of which, and the resulting clinical effects, vary substantially from unit to unit.Consider insulin.For decades, patients received crude pancreatic extracts of inconsistent potency.4 However, the advent of purified, and then recombinant, insulin, with defined purity and dose, and with predictable pharmacokinetics, revolutionized diabetes care and became the widely accepted standard.4 As a result, no endocrinologist would return to the use of variable animal extracts because they "worked well enough."Nonetheless, most of transfusion medicine remains in its pre-pharmaceutical era, administering blood components whose therapeutic effects cannot be precisely predicted from the dose given,

Schlagwörter

Stichwörter der Autor:innen

blood componentsfactor concentratespharmaceuticalplasmaplateletsprecision medicinered blood cellstransfusion medicine

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
  • Department of Pathology and Cell Biology, Columbia University, New York, New York, USA.

ORCID-Profile: Melissa M Cushing, Steven L Spitalnik

Zitieren

APA

Cushing, M. M., & Spitalnik, S. L. (2026). From components to pharmaceuticals: A desirable evolution toward precision transfusion medicine. Transfusion, 66(11), 2450-2455. https://doi.org/10.1111/trf.70402

Vancouver

Cushing MM, Spitalnik SL. From components to pharmaceuticals: A desirable evolution toward precision transfusion medicine. Transfusion. 2026;66(11):2450-2455. doi:10.1111/trf.70402

BibTeX
@article{Cushing2026,
  author = {Cushing, Melissa M and Spitalnik, Steven L},
  title = {From components to pharmaceuticals: A desirable evolution toward precision transfusion medicine},
  journal = {Transfusion},
  year = {2026},
  volume = {66},
  number = {11},
  pages = {2450--2455},
  doi = {10.1111/trf.70402}
}
Kostenlos starten →